Drugs / Human insulin isophane suspension (NPH)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00191282 | Oct 2002 → Oct 2007 | acute myocardial infarction, type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human insulin isophane suspension (NPH) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00191282 ↗ |
| Route | Subcutaneous | “injected subcutaneous (SC) until patient completes study” NCT00191282 ↗ |